Thomas Hartle, the first Canadian to use psilocybin therapy for end-of-life anxiety, is back in the news. His story, now featured again in The Guardian, explores global perspectives on psychedelics, psilocybin therapy’s scientific validation and the ongoing challenges and regulatory barriers to accessing psychedelics.